APO Research

APO RESEARCH · REPORT

Kidney Transplant Medicine

Selected research

Industry Growth & Trends

Global Kidney Transplant Medicine Industry Growth and Trends Forecast to 2032

Market perspective

The global Kidney Transplant Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kidney Transplant Medicine include Sanofi, Novartis, Pfizer, GlaxoSmithKline plc, Veloxis Pharmaceuticals, Roche Pharmaceuticals, Prometheus Laboratories, Mayne Pharma Group Limited and Hansa Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Kidney Transplant Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Kidney Transplant Medicine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kidney Transplant Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kidney Transplant Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Kidney Transplant Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Kidney Transplant Medicine Market by Company

Sanofi

Novartis

Pfizer

GlaxoSmithKline plc

Veloxis Pharmaceuticals

Roche Pharmaceuticals

Prometheus Laboratories

Mayne Pharma Group Limited

Hansa Biopharma

BHARAT SERUM

Astellas Pharma

Kidney Transplant Medicine Segment by Type

Tacrolimus

Mycophenolate

Azathioprine

Ciclosporin

Other

Kidney Transplant Medicine Segment by Application

Online Sales

Offline Sales

Kidney Transplant Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kidney Transplant Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Kidney Transplant Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tacrolimus Table 2. Major Company of Mycophenolate Table 3. Major Company of Azathioprine Table 4. Major Company of Ciclosporin Table 5. Major Company of Other Table 6. Global Kidney Transplant Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Kidney Transplant Medicine Sales by Type (2021-2026) & (k units) Table 8. Global Kidney Transplant Medicine Sales Market Share in Volume by Type (2021-2026) Table 9. Global Kidney Transplant Medicine Sales by Type (2021-2026) & (US$ Million) Table 10. Global Kidney Transplant Medicine Sales Market Share in Value by Type (2021-2026) Table 11. Global Kidney Transplant Medicine Price by Type (2021-2026) & (USD/unit) Table 12. Global Kidney Transplant Medicine Sales by Type (2027-2032) & (k units) Table 13. Global Kidney Transplant Medicine Sales Market Share in Volume by Type (2027-2032) Table 14. Global Kidney Transplant Medicine Sales by Type (2027-2032) & (US$ Million) Table 15. Global Kidney Transplant Medicine Sales Market Share in Value by Type (2027-2032) Table 16. Global Kidney Transplant Medicine Price by Type (2027-2032) & (USD/unit) Table 17. North America Kidney Transplant Medicine Sales by Type (2021-2026) & (k units) Table 18. North America Kidney Transplant Medicine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Kidney Transplant Medicine Sales by Type (2021-2026) & (k units) Table 20. Europe Kidney Transplant Medicine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Kidney Transplant Medicine Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Kidney Transplant Medicine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Kidney Transplant Medicine Sales by Type (2021-2026) & (k units) Table 24. Latin America Kidney Transplant Medicine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Kidney Transplant Medicine Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Kidney Transplant Medicine Sales by Type (2021-2026) & (US$ Million) Table 27. Kidney Transplant Medicine Industry Trends Table 28. Kidney Transplant Medicine Industry Drivers Table 29. Kidney Transplant Medicine Industry Opportunities and Challenges Table 30. Kidney Transplant Medicine Industry Restraints Table 31. Global Kidney Transplant Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Kidney Transplant Medicine Revenue Market Share by Company (2021-2026) Table 33. Global Kidney Transplant Medicine Sales by Company (2021-2026) & (k units) Table 34. Global Kidney Transplant Medicine Sales Share by Company (2021-2026) Table 35. Global Kidney Transplant Medicine Market Price by Company (2021-2026) & (USD/unit) Table 36. Global Kidney Transplant Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Kidney Transplant Medicine Major Company Production Sites and Headquarters Table 38. Global Kidney Transplant Medicine Company, Product Type & Application Table 39. Global Kidney Transplant Medicine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Kidney Transplant Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Kidney Transplant Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Kidney Transplant Medicine Sales by Region (2021-2026) & (k units) Table 44. Global Kidney Transplant Medicine Sales Market Share in Volume by Region (2021-2026) Table 45. Global Kidney Transplant Medicine Sales by Region (2021-2026) & (US$ Million) Table 46. Global Kidney Transplant Medicine Sales Market Share in Value by Region (2021-2026) Table 47. Global Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 48. Global Kidney Transplant Medicine Sales by Region (2027-2032) & (k units) Table 49. Global Kidney Transplant Medicine Sales Market Share in Volume by Region (2027-2032) Table 50. Global Kidney Transplant Medicine Sales by Region (2027-2032) & (US$ Million) Table 51. Global Kidney Transplant Medicine Sales Market Share in Value by Region (2027-2032) Table 52. Global Kidney Transplant Medicine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 53. Global Kidney Transplant Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Kidney Transplant Medicine Sales by Application (2021-2026) & (k units) Table 55. Global Kidney Transplant Medicine Sales Market Share in Volume by Application (2021-2026) Table 56. Global Kidney Transplant Medicine Sales by Application (2021-2026) & (US$ Million) Table 57. Global Kidney Transplant Medicine Sales Market Share in Value by Application (2021-2026) Table 58. Global Kidney Transplant Medicine Price by Application (2021-2026) & (USD/unit) Table 59. Global Kidney Transplant Medicine Sales by Application (2027-2032) & (k units) Table 60. Global Kidney Transplant Medicine Sales Market Share in Volume by Application (2027-2032) Table 61. Global Kidney Transplant Medicine Sales by Application (2027-2032) & (US$ Million) Table 62. Global Kidney Transplant Medicine Sales Market Share in Value by Application (2027-2032) Table 63. Global Kidney Transplant Medicine Price by Application (2027-2032) & (USD/unit) Table 64. North America Kidney Transplant Medicine Sales by Application (2021-2026) & (k units) Table 65. North America Kidney Transplant Medicine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Kidney Transplant Medicine Sales by Application (2021-2026) & (k units) Table 67. Europe Kidney Transplant Medicine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Kidney Transplant Medicine Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Kidney Transplant Medicine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Kidney Transplant Medicine Sales by Application (2021-2026) & (k units) Table 71. Latin America Kidney Transplant Medicine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Kidney Transplant Medicine Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Kidney Transplant Medicine Sales by Application (2021-2026) & (US$ Million) Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Sanofi Kidney Transplant Medicine Product Portfolio Table 78. Sanofi Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Novartis Kidney Transplant Medicine Product Portfolio Table 83. Novartis Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Pfizer Kidney Transplant Medicine Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline plc Company Information Table 90. GlaxoSmithKline plc Business Overview Table 91. GlaxoSmithKline plc Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio Table 93. GlaxoSmithKline plc Recent Development Table 94. Veloxis Pharmaceuticals Company Information Table 95. Veloxis Pharmaceuticals Business Overview Table 96. Veloxis Pharmaceuticals Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio Table 98. Veloxis Pharmaceuticals Recent Development Table 99. Roche Pharmaceuticals Company Information Table 100. Roche Pharmaceuticals Business Overview Table 101. Roche Pharmaceuticals Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio Table 103. Roche Pharmaceuticals Recent Development Table 104. Prometheus Laboratories Company Information Table 105. Prometheus Laboratories Business Overview Table 106. Prometheus Laboratories Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Prometheus Laboratories Kidney Transplant Medicine Product Portfolio Table 108. Prometheus Laboratories Recent Development Table 109. Mayne Pharma Group Limited Company Information Table 110. Mayne Pharma Group Limited Business Overview Table 111. Mayne Pharma Group Limited Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio Table 113. Mayne Pharma Group Limited Recent Development Table 114. Hansa Biopharma Company Information Table 115. Hansa Biopharma Business Overview Table 116. Hansa Biopharma Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Hansa Biopharma Kidney Transplant Medicine Product Portfolio Table 118. Hansa Biopharma Recent Development Table 119. BHARAT SERUM Company Information Table 120. BHARAT SERUM Business Overview Table 121. BHARAT SERUM Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. BHARAT SERUM Kidney Transplant Medicine Product Portfolio Table 123. BHARAT SERUM Recent Development Table 124. Astellas Pharma Company Information Table 125. Astellas Pharma Business Overview Table 126. Astellas Pharma Kidney Transplant Medicine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Astellas Pharma Kidney Transplant Medicine Product Portfolio Table 128. Astellas Pharma Recent Development Table 129. North America Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. North America Kidney Transplant Medicine Sales by Country (2021-2026) & (k units) Table 131. North America Kidney Transplant Medicine Sales Market Share by Country (2021-2026) Table 132. North America Kidney Transplant Medicine Sales Forecast by Country (2027-2032) & (k units) Table 133. North America Kidney Transplant Medicine Sales Market Share Forecast by Country (2027-2032) Table 134. North America Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Kidney Transplant Medicine Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Kidney Transplant Medicine Market Share by Country (2021-2026) Table 137. North America Kidney Transplant Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Kidney Transplant Medicine Market Share Forecast by Country (2027-2032) Table 139. Europe Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Europe Kidney Transplant Medicine Sales by Country (2021-2026) & (k units) Table 141. Europe Kidney Transplant Medicine Sales Market Share by Country (2021-2026) Table 142. Europe Kidney Transplant Medicine Sales Forecast by Country (2027-2032) & (k units) Table 143. Europe Kidney Transplant Medicine Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Kidney Transplant Medicine Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Kidney Transplant Medicine Market Share by Country (2021-2026) Table 147. Europe Kidney Transplant Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Kidney Transplant Medicine Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Kidney Transplant Medicine Sales by Country (2021-2026) & (k units) Table 151. Asia-Pacific Kidney Transplant Medicine Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Kidney Transplant Medicine Sales Forecast by Country (2027-2032) & (k units) Table 153. Asia-Pacific Kidney Transplant Medicine Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Kidney Transplant Medicine Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Kidney Transplant Medicine Market Share by Country (2021-2026) Table 157. Asia-Pacific Kidney Transplant Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Kidney Transplant Medicine Market Share Forecast by Country (2027-2032) Table 159. Latin America Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Latin America Kidney Transplant Medicine Sales by Country (2021-2026) & (k units) Table 161. Latin America Kidney Transplant Medicine Sales Market Share by Country (2021-2026) Table 162. Latin America Kidney Transplant Medicine Sales Forecast by Country (2027-2032) & (k units) Table 163. Latin America Kidney Transplant Medicine Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Kidney Transplant Medicine Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Kidney Transplant Medicine Market Share by Country (2021-2026) Table 167. Latin America Kidney Transplant Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Kidney Transplant Medicine Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Kidney Transplant Medicine Sales by Country (2021-2026) & (k units) Table 171. Middle East and Africa Kidney Transplant Medicine Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Kidney Transplant Medicine Sales Forecast by Country (2027-2032) & (k units) Table 173. Middle East and Africa Kidney Transplant Medicine Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Kidney Transplant Medicine Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Kidney Transplant Medicine Market Share by Country (2021-2026) Table 177. Middle East and Africa Kidney Transplant Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Kidney Transplant Medicine Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Kidney Transplant Medicine Distributors List Table 182. Kidney Transplant Medicine Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Kidney Transplant Medicine Image Figure 2. Global Kidney Transplant Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Transplant Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Kidney Transplant Medicine Sales (2021-2032) & (k units) Figure 5. Tacrolimus Image Figure 6. Global Tacrolimus Sales YoY Growth (2021-2032) & (k units) Figure 7. Mycophenolate Image Figure 8. Global Mycophenolate Sales YoY Growth (2021-2032) & (k units) Figure 9. Azathioprine Image Figure 10. Global Azathioprine Sales YoY Growth (2021-2032) & (k units) Figure 11. Ciclosporin Image Figure 12. Global Ciclosporin Sales YoY Growth (2021-2032) & (k units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Kidney Transplant Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Kidney Transplant Medicine Market Share by Type 2025 VS 2032 Figure 17. North America Kidney Transplant Medicine Sales Market Share in Volume by Type in 2025 Figure 18. North America Kidney Transplant Medicine Sales Market Share in Value by Type in 2025 Figure 19. Europe Kidney Transplant Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Europe Kidney Transplant Medicine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Kidney Transplant Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Kidney Transplant Medicine Sales Market Share in Value by Type in 2025 Figure 23. Latin America Kidney Transplant Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Kidney Transplant Medicine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Kidney Transplant Medicine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Kidney Transplant Medicine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Kidney Transplant Medicine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Online Sales Image Figure 30. Global Online Sales Sales YoY Growth (2021-2032) & (k units) Figure 31. Offline Sales Image Figure 32. Global Offline Sales Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Kidney Transplant Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Kidney Transplant Medicine Market Share by Application 2025 VS 2032 Figure 35. North America Kidney Transplant Medicine Sales Market Share in Volume by Application in 2025 Figure 36. North America Kidney Transplant Medicine Sales Market Share in Value by Application in 2025 Figure 37. Europe Kidney Transplant Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Kidney Transplant Medicine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Kidney Transplant Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Kidney Transplant Medicine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Kidney Transplant Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Kidney Transplant Medicine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Kidney Transplant Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Kidney Transplant Medicine Sales Market Share in Value by Application in 2025 Figure 45. North America Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Kidney Transplant Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Kidney Transplant Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Kidney Transplant Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Kidney Transplant Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Kidney Transplant Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Kidney Transplant Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Kidney Transplant Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Kidney Transplant Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Kidney Transplant Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Kidney Transplant Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Kidney Transplant Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Kidney Transplant Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Kidney Transplant Medicine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Kidney Transplant Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tacrolimus
  • Mycophenolate
  • Azathioprine
  • Ciclosporin
  • Other
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Sanofi
  • Novartis
  • Pfizer
  • GlaxoSmithKline plc
  • Veloxis Pharmaceuticals
  • Roche Pharmaceuticals
  • Prometheus Laboratories
  • Mayne Pharma Group Limited
  • Hansa Biopharma
  • BHARAT SERUM
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kidney Transplant Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Kidney Transplant Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Kidney Transplant Medicine Market by Type
  6. 1.3.1 Tacrolimus
  7. 1.3.2 Mycophenolate
  8. 1.3.3 Azathioprine
  9. 1.3.4 Ciclosporin
  10. 1.3.5 Other
  11. 1.4 Global Kidney Transplant Medicine Market Size by Type
  12. 1.4.1 Global Kidney Transplant Medicine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Kidney Transplant Medicine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Kidney Transplant Medicine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Kidney Transplant Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Kidney Transplant Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Kidney Transplant Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Kidney Transplant Medicine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Kidney Transplant Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Kidney Transplant Medicine Industry Trends
  2. 2.2 Kidney Transplant Medicine Industry Drivers
  3. 2.3 Kidney Transplant Medicine Industry Opportunities and Challenges
  4. 2.4 Kidney Transplant Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Kidney Transplant Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Kidney Transplant Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Kidney Transplant Medicine Price (2021-2026)
  4. 3.4 Global Kidney Transplant Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kidney Transplant Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Kidney Transplant Medicine Company, Product Type & Application
  7. 3.7 Global Kidney Transplant Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kidney Transplant Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kidney Transplant Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kidney Transplant Medicine Tier 1, Tier 2, and Tier 3
4 Kidney Transplant Medicine Regional Status and Outlook
  1. 4.1 Global Kidney Transplant Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Kidney Transplant Medicine Historic Market Size by Region
  3. 4.2.1 Global Kidney Transplant Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Kidney Transplant Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Kidney Transplant Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Kidney Transplant Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Kidney Transplant Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Kidney Transplant Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Kidney Transplant Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Kidney Transplant Medicine by Application
  1. 5.1 Kidney Transplant Medicine Market by Application
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Kidney Transplant Medicine Market Size by Application
  5. 5.2.1 Global Kidney Transplant Medicine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Kidney Transplant Medicine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Kidney Transplant Medicine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Kidney Transplant Medicine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Kidney Transplant Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Kidney Transplant Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Kidney Transplant Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Kidney Transplant Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Kidney Transplant Medicine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Kidney Transplant Medicine Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Kidney Transplant Medicine Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline plc
  20. 6.4.1 GlaxoSmithKline plc Company Information
  21. 6.4.2 GlaxoSmithKline plc Business Overview
  22. 6.4.3 GlaxoSmithKline plc Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio
  24. 6.4.5 GlaxoSmithKline plc Recent Developments
  25. 6.5 Veloxis Pharmaceuticals
  26. 6.5.1 Veloxis Pharmaceuticals Company Information
  27. 6.5.2 Veloxis Pharmaceuticals Business Overview
  28. 6.5.3 Veloxis Pharmaceuticals Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio
  30. 6.5.5 Veloxis Pharmaceuticals Recent Developments
  31. 6.6 Roche Pharmaceuticals
  32. 6.6.1 Roche Pharmaceuticals Company Information
  33. 6.6.2 Roche Pharmaceuticals Business Overview
  34. 6.6.3 Roche Pharmaceuticals Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio
  36. 6.6.5 Roche Pharmaceuticals Recent Developments
  37. 6.7 Prometheus Laboratories
  38. 6.7.1 Prometheus Laboratories Company Information
  39. 6.7.2 Prometheus Laboratories Business Overview
  40. 6.7.3 Prometheus Laboratories Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Prometheus Laboratories Kidney Transplant Medicine Product Portfolio
  42. 6.7.5 Prometheus Laboratories Recent Developments
  43. 6.8 Mayne Pharma Group Limited
  44. 6.8.1 Mayne Pharma Group Limited Company Information
  45. 6.8.2 Mayne Pharma Group Limited Business Overview
  46. 6.8.3 Mayne Pharma Group Limited Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio
  48. 6.8.5 Mayne Pharma Group Limited Recent Developments
  49. 6.9 Hansa Biopharma
  50. 6.9.1 Hansa Biopharma Company Information
  51. 6.9.2 Hansa Biopharma Business Overview
  52. 6.9.3 Hansa Biopharma Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hansa Biopharma Kidney Transplant Medicine Product Portfolio
  54. 6.9.5 Hansa Biopharma Recent Developments
  55. 6.10 BHARAT SERUM
  56. 6.10.1 BHARAT SERUM Company Information
  57. 6.10.2 BHARAT SERUM Business Overview
  58. 6.10.3 BHARAT SERUM Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BHARAT SERUM Kidney Transplant Medicine Product Portfolio
  60. 6.10.5 BHARAT SERUM Recent Developments
  61. 6.11 Astellas Pharma
  62. 6.11.1 Astellas Pharma Company Information
  63. 6.11.2 Astellas Pharma Business Overview
  64. 6.11.3 Astellas Pharma Kidney Transplant Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astellas Pharma Kidney Transplant Medicine Product Portfolio
  66. 6.11.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Kidney Transplant Medicine Sales by Country
  2. 7.1.1 North America Kidney Transplant Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Kidney Transplant Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Kidney Transplant Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Kidney Transplant Medicine Market Size by Country
  6. 7.2.1 North America Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Kidney Transplant Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Kidney Transplant Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Kidney Transplant Medicine Sales by Country
  2. 8.1.1 Europe Kidney Transplant Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Kidney Transplant Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Kidney Transplant Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Kidney Transplant Medicine Market Size by Country
  6. 8.2.1 Europe Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Kidney Transplant Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Kidney Transplant Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Kidney Transplant Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Kidney Transplant Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Kidney Transplant Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Kidney Transplant Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Kidney Transplant Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Kidney Transplant Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Kidney Transplant Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Kidney Transplant Medicine Sales by Country
  2. 10.1.1 South America Kidney Transplant Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Kidney Transplant Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Kidney Transplant Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Kidney Transplant Medicine Market Size by Country
  6. 10.2.1 South America Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Kidney Transplant Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Kidney Transplant Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Kidney Transplant Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Kidney Transplant Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Kidney Transplant Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Kidney Transplant Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Kidney Transplant Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Kidney Transplant Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Kidney Transplant Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Kidney Transplant Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Kidney Transplant Medicine Value Chain Analysis
  2. 12.1.1 Kidney Transplant Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Kidney Transplant Medicine Production Mode & Process
  7. 12.2 Kidney Transplant Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Kidney Transplant Medicine Distributors
  10. 12.2.3 Kidney Transplant Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research